- The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity
Muna Suleiman et al, 2024, Journal of Cardiovascular Translational Research CrossRef - Screening of break point cluster region Abelson tyrosine kinase inhibitors by capillary electrophoresis
Mei Xu et al, 2018, Journal of Chromatography A CrossRef - Celery
Phetcharat Boonruamkaew et al, 2020, Nutritional Composition and Antioxidant Properties of Fruits and Vegetables CrossRef - RETRACTED: Luteolin retards CXCL12-induced Jurkat cells migration by disrupting transcription of CXCR4
Yunwen Bu et al, 2020, Experimental and Molecular Pathology CrossRef - Bioactive Compounds from Curcuma amada and Their Effect on Acute Myeloid Leukemia
Ajila Chandran et al, 2022, Critical Reviews™ in Oncogenesis CrossRef - Recent Advances in Natural Products with Anti-Leukemia and Anti- Lymphoma Activities
Zhi-Gang Sun et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef - Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2
Li Wang et al, 2019, Phytotherapy Research CrossRef - Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds
Maria do Socorro S. Chagas et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef - Therapeutic effects of Sheng Xue Fang in a cyclophosphamide-induced anaemia mouse model
Lu Dou et al, 2021, Pharmaceutical Biology CrossRef - Modulation of drug resistance in leukemia using phytochemicals: an in-silico, in-vitro, and in-vivo approach
Urja Desai et al, 2023, Recent Frontiers of Phytochemicals CrossRef - Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein
Pei-Yi Chen et al, 2018, International Journal of Molecular Sciences CrossRef - Stimulation of Fas/FasL‐mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c‐Jun activation in HL‐60 leukemia cells
Shih‐Wei Wang et al, 2018, Molecular Carcinogenesis CrossRef - Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development
Debasis Patnaik et al, 2018, Oncotarget CrossRef - The Anti-Leukemic Activity of Natural Compounds
Coralia Cotoraci et al, 2021, Molecules CrossRef - Efficacy of the plantago major L. syrup on radiation induced oral mucositis in head and neck cancer patients: A randomized, double blind, placebo-controlled clinical trial
Gholamreza Mohammad Soltani et al, 2020, Complementary Therapies in Medicine CrossRef - Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia
Harsh Goel et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics
Kun Han et al, 2018, Scientific Reports CrossRef - Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li et al, 2019, Phytomedicine CrossRef - Flavonoids as Potential Anticancer Agents in Clinics: Where Have We Reached So Far?
Balbir Singh et al, 2019, Current Aspects of Flavonoids: Their Role in Cancer Treatment CrossRef - Luteolin induces myelodysplastic syndrome‑derived cell apoptosis via the p53‑dependent mitochondrial signaling pathway mediated by reactive oxygen species
Weimin Dong et al, 2018, International Journal of Molecular Medicine CrossRef - RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges
Ying Sun et al, 2023, European Journal of Medicinal Chemistry CrossRef - Luteolin inhibits melanoma growth in vitro and in vivo via regulating ECM and oncogenic pathways but not ROS
John Schomberg et al, 2020, Biochemical Pharmacology CrossRef - Natural Product Luteolin Rescues THAP-Induced Pancreatic β-Cell Dysfunction through HNF4α Pathway
Wenyu Wu et al, 2020, The American Journal of Chinese Medicine CrossRef